Keyphrases
Sodium Nitroprusside
100%
Human Aortic Smooth muscle Cells (HASMCs)
100%
Tolerance Mechanisms
100%
Cyclic GMP
58%
Soluble Guanylate Cyclase
33%
Zaprinast
25%
Protein Kinase
16%
Smooth muscle Cells
16%
Protein Level
16%
Reducing Agent
16%
S-nitroso-N-acetylpenicillamine
16%
Phosphodiesterase Inhibitors
16%
Oxyhemoglobin
8%
Cell Culture Model
8%
Dose Effect
8%
Possible Mechanisms
8%
Western Blot Analysis
8%
MRNA Level
8%
Steady State
8%
Distinct Mechanism
8%
Intact Cells
8%
Concentration-dependent
8%
Incubation
8%
Northern Blot Analysis
8%
Early Onset
8%
Thiols
8%
Co-incubation
8%
Sensitive Business Process
8%
Immunology and Microbiology
Downregulation
100%
Aortic Smooth Muscle Cell
100%
Zaprinast
100%
Smooth Muscle Cell
66%
Cell Culture
33%
Steady State
33%
Western Blot
33%
Northern Blotting
33%
Pharmacology, Toxicology and Pharmaceutical Science
Nitroprusside Sodium
100%
Cyclic GMP
58%
Guanylate Cyclase
33%
Zaprinast
25%
S-Nitroso-N-Acetylpenicillamine
16%
H-89
16%
Reducing Agent
16%
Phosphodiesterase Inhibitor
16%
Cell Culture
8%
Oxyhemoglobin
8%
Western Blot
8%
Cyclic AMP Dependent Protein Kinase
8%
Cyclic AMP Dependent Protein Kinase Inhibitor
8%
Messenger RNA
8%
Thiol
8%
Neuroscience
Sodium Nitroprusside
100%
Cyclic Guanosine Monophosphate
58%
Guanylate Cyclase
33%
Zaprinast
25%
Protein Kinase A
16%
Reducing Agent
16%
H-89
16%
Phosphodiesterase Inhibitor
16%
Oxyhemoglobin
8%
Cell Culture
8%
Northern Blot
8%
Western Blotting
8%
Messenger RNA
8%
Thiol
8%